Can Locoregionally Recurrent Breast Cancer Be Cured?

Arati Rani Chand, M. Firdos Ziauddin, Shou Ching Tang

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer. With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.

Original languageEnglish (US)
Pages (from-to)326-335
Number of pages10
JournalClinical Breast Cancer
Volume17
Issue number5
DOIs
StatePublished - Aug 2017

Fingerprint

Breast Neoplasms
Recurrence
Therapeutics
Retrospective Studies
Incidence
Neoplasms

Keywords

  • Locoregional recurrence
  • Prognosis
  • Radiation
  • Surgery
  • Systemic therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Can Locoregionally Recurrent Breast Cancer Be Cured? / Chand, Arati Rani; Ziauddin, M. Firdos; Tang, Shou Ching.

In: Clinical Breast Cancer, Vol. 17, No. 5, 08.2017, p. 326-335.

Research output: Contribution to journalReview article

Chand, Arati Rani ; Ziauddin, M. Firdos ; Tang, Shou Ching. / Can Locoregionally Recurrent Breast Cancer Be Cured?. In: Clinical Breast Cancer. 2017 ; Vol. 17, No. 5. pp. 326-335.
@article{1a1c1cdc01c34684bc8bb681960ee10b,
title = "Can Locoregionally Recurrent Breast Cancer Be Cured?",
abstract = "Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer. With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.",
keywords = "Locoregional recurrence, Prognosis, Radiation, Surgery, Systemic therapy",
author = "Chand, {Arati Rani} and Ziauddin, {M. Firdos} and Tang, {Shou Ching}",
year = "2017",
month = "8",
doi = "10.1016/j.clbc.2017.02.007",
language = "English (US)",
volume = "17",
pages = "326--335",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Can Locoregionally Recurrent Breast Cancer Be Cured?

AU - Chand, Arati Rani

AU - Ziauddin, M. Firdos

AU - Tang, Shou Ching

PY - 2017/8

Y1 - 2017/8

N2 - Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer. With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.

AB - Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer. With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.

KW - Locoregional recurrence

KW - Prognosis

KW - Radiation

KW - Surgery

KW - Systemic therapy

UR - http://www.scopus.com/inward/record.url?scp=85016607730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016607730&partnerID=8YFLogxK

U2 - 10.1016/j.clbc.2017.02.007

DO - 10.1016/j.clbc.2017.02.007

M3 - Review article

C2 - 28365334

AN - SCOPUS:85016607730

VL - 17

SP - 326

EP - 335

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - 5

ER -